Business Context and Reporting Period
Company: On Assignment, Inc. (Note: Input metadata listed "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2007
Business Overview: A diversified professional staffing firm operating in four segments: Life Sciences, Healthcare, Physician, and IT and Engineering. The reporting period was defined by the integration of two major acquisitions: VISTA Staffing Solutions (Physician segment) acquired January 3, 2007, and Oxford Global Resources (IT and Engineering segment) acquired January 31, 2007.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2007 |
Six Months Ended June 30, 2006 |
Three Months Ended June 30, 2007 |
Three Months Ended June 30, 2006 |
|---|---|---|---|---|
| Revenues | $266,483,000 | $135,359,000 | $143,854,000 | $68,636,000 |
| Gross Profit | $83,701,000 | $36,252,000 | $46,241,000 | $19,268,000 |
| Gross Margin | 31.4% | 26.8% | 32.1% | 28.1% |
| Operating Income | $10,448,000 | $2,822,000 | $7,249,000 | $2,624,000 |
| Net Income | $3,849,000 | $2,216,000 | $2,938,000 | $1,914,000 |
| Diluted EPS | $0.11 | $0.08 | $0.08 | $0.07 |
| Cash from Operations | $13,846,000 | $9,355,000 | N/A | N/A |
| Cash & Equivalents (End of Period) | $29,383,000 | $28,611,000 | $29,383,000 | $28,611,000 |
| Total Debt (Notes Payable) | $144,275,000 | $0 | $144,275,000 | $0 |
| Working Capital | $76,681,000 | N/A | $76,681,000 | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenue increased 96.9% year-over-year for the six months ended June 30, 2007. This growth is primarily attributable to the inclusion of VISTA and Oxford revenues post-acquisition, alongside organic growth in Life Sciences (17.2% increase) and Healthcare (8.1% increase) segments.
- Margin Expansion: Consolidated gross margin improved by 460 basis points to 31.4% for the six-month period. This was driven by the high-margin IT and Engineering segment (37.2%) and improved bill/pay spreads in legacy segments.
- Debt Financing: The company entered a $165 million senior secured credit facility in January 2007 to finance the Oxford acquisition. This resulted in a significant increase in interest expense ($5.1 million for six months 2007 vs. $3,000 in 2006).
- Balance Sheet Expansion: Total assets nearly doubled from $187 million to $375 million, driven by $187 million in goodwill and $49 million in identifiable intangible assets recorded from the acquisitions.
- SG&A Expenses: Selling, general, and administrative expenses increased 119.1% year-over-year, largely due to amortization of acquired intangibles ($7.9 million) and increased headcount.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: Management expects continued revenue growth in the Physician and IT/Engineering segments due to supply/demand imbalances. They anticipate leveraging SG&A synergies across the new and legacy businesses.
- Unusual Items:
- Acquisition Costs: Significant non-cash amortization of intangibles ($7.9 million for six months) and stock-based compensation ($3.3 million) impacted operating income.
- Swap Gain: A $431,000 gain was recorded on an interest rate swap agreement used to fix rates on $73 million of debt.
- Tax Provision: The effective tax rate increased to approximately 40% in 2007 following the full reversal of a valuation allowance on deferred tax assets at the end of 2006.
- Risks and Contingencies:
- Legal Proceedings: Ongoing litigation (Oxford vs. Black Diamond) regarding non-compete agreements and misappropriation of trade secrets. Discovery is ongoing with a trial anticipated in late January 2008.
- Contractor Classification: Risk that taxing authorities may reclassify independent contractor physicians as employees, potentially resulting in significant retroactive tax and wage liabilities.
- Self-Insurance: The company is partially self-insured for workers' compensation and medical malpractice, with a liability of $8.2 million as of June 30, 2007.
Investor Verification Checklist
- Acquisition Integration: Verify the realization of projected SG&A synergies and the stability of revenue from the newly acquired VISTA and Oxford segments.
- Debt Covenants: Monitor compliance with the $165 million credit facility covenants, specifically the minimum total leverage ratio and interest coverage ratio.
- Intangible Asset Amortization: Assess the impact of the $7.9 million amortization expense on future earnings, noting that this is a non-cash charge that will decrease as assets are fully amortized.
- Legal Exposure: Track the status of the Oxford vs. Black Diamond litigation and potential financial impact of the trial scheduled for early 2008.
- Contractor Status: Review the company's defense regarding the classification of locum tenens physicians as independent contractors versus employees.